Congenica is a leading provider of clinical decision support software and services which has developed the gold-standard platform, Sapientia, for analysis, interpretation and generation of clinically actionable reports on patient derived genomic data. Headquartered at the Wellcome Genome Campus, Cambridge, UK, Sapientia’s underlying technology was spun out of the pioneering research from the Sanger Institute and the platform continues to be developed by the well-renowned scientific staff and advisers.
Congenica aims to integrate genomics into healthcare by providing clinical genome analytics to support medical practitioners treating patients with genetic diseases, and thereby improving human health and personalised patient care. The company is at the forefront of partnering with leading clinical research and healthcare providers, charities and patient advocacy groups and diagnostic companies to create new medical paradigms in orphan diseases.
In the media
17th October 2018
Congenica earns major role in supporting world’s first routine national genomic medicine service
6th December 2018
NGS Data Analysis Market: Emerging Economies Expected to Influence Growth until 2026
FactMR’s report has listed key companies underpinning expansion of the global market for NGS data analysis, which include Advaita, Bina Technologies (Roche), Congenica, DNASTAR, Eagle Genomics, Flatiron, GENEWIZ, Qiagen, and Thermo
5th December 2018
Global Next Generation Sequencing (NGS) Data Analysis Market: Key Players Such As Qiagen, Advaita Bioinformatics, Roche, Biomatters, Illumina and Congenica
Researchmoz added Most up-to-date research on "Global : Key Players Such As Qiagen, Advaita Bioinformatics, Roche, Biomatters, Illumina and Congenica" to its huge collection of research reports. North America is home to